These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8778347)

  • 1. [Pharmacology of 5-hydroxytryptamine receptors].
    Fontaine J
    J Pharm Belg; 1996; 51(3):141-51. PubMed ID: 8778347
    [No Abstract]   [Full Text] [Related]  

  • 2. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
    Heightman TD; Gaster LM; Pardoe SL; Pilleux JP; Hadley MS; Middlemiss DN; Price GW; Roberts C; Scott CM; Watson JM; Gordon LJ; Holland VA; Powles J; Riley GJ; Stean TO; Trail BK; Upton N; Austin NE; Ayrton AD; Coleman T; Cutler L
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4370-4. PubMed ID: 16039851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cardiovascular effects of serotonin receptor agonists and antagonists (I)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(5):441-7. PubMed ID: 8291931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serotonin receptors (results of the pharmacological study)].
    Valeeva LA; Sergeev PV; Shimanovskiĭ NL
    Eksp Klin Farmakol; 1997; 60(6):57-61. PubMed ID: 9460603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cardiovascular effects of serotonin receptor agonists and antagonists (II)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(6):553-61. PubMed ID: 8135597
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
    Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
    J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin1C,2 receptors and endurance performance. An illustration of the limits of pharmacological tools in exercise science.
    Chaouloff F
    Int J Sports Med; 1994 Aug; 15(6):339-11. PubMed ID: 7822075
    [No Abstract]   [Full Text] [Related]  

  • 8. [(3)H]-serotonin release from bovine iris-ciliary body: pharmacology of prejunctional serotonin (5-HT(7)) autoreceptors.
    Harris LC; Awe SO; Opere CA; Leday AM; Ohia SE; Sharif NA
    Exp Eye Res; 2001 Jul; 73(1):59-67. PubMed ID: 11428863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of 5-HT1 and 5-HT2 serotonin receptor agonists and antagonists on predator aggression in wild Norway rats].
    Popova NK; Nikulina EM; Shigantsov SN; Pliusnina IF; Amstislavskaia TG
    Biull Eksp Biol Med; 1996 Jun; 121(6):687-9. PubMed ID: 9035768
    [No Abstract]   [Full Text] [Related]  

  • 10. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
    Wesołowska A
    Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
    Glennon RA
    J Med Chem; 2003 Jul; 46(14):2795-812. PubMed ID: 12825922
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin: a review.
    Mohammad-Zadeh LF; Moses L; Gwaltney-Brant SM
    J Vet Pharmacol Ther; 2008 Jun; 31(3):187-99. PubMed ID: 18471139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin receptor subtype anxiolytic agent].
    Zhang ZQ
    Sheng Li Ke Xue Jin Zhan; 1993 Oct; 24(4):358-60. PubMed ID: 7911252
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors.
    Tonini M
    Neurogastroenterol Motil; 2005 Oct; 17(5):637-42. PubMed ID: 16185301
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
    McCall RB; Clement ME
    Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
    [No Abstract]   [Full Text] [Related]  

  • 16. Problems of drug selectivity and dose--pharmacology.
    Ramage A
    J Physiol; 2005 Dec; 569(Pt 2):711; author reply 712. PubMed ID: 16322062
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 1999 Oct; 291(1):300-7. PubMed ID: 10490917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
    Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
    Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel actions of inverse agonists on 5-HT2C receptor systems.
    Berg KA; Stout BD; Cropper JD; Maayani S; Clarke WP
    Mol Pharmacol; 1999 May; 55(5):863-72. PubMed ID: 10220565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.